A -year-old man with a history of hypertension undergoes an abdominal ultrasound for mild right upper quadrant pain. The ultrasound incidentally identifies a -cm solid mass in the right adrenal gland. Subsequent biochemical screening for hypercortisolism, primary aldosteronism, and pheochromocytoma is entirely normal. Arrange the following diagnostic modalities in the correct evidence-based sequence for characterizing this adrenal incidentaloma, starting with the initial preferred imaging study and ending with the most invasive diagnostic step of last resort.
- 1Non-contrast computed tomography (CT) of the adrenal glands
- 2Adrenal protocol CT with delayed contrast washout imaging
- 3Fluorodeoxyglucose positron emission tomography (FDG-PET) scan
- 4Image-guided percutaneous core needle biopsy
Cevap
The correct sequence for characterizing an indeterminate adrenal incidentaloma is: Non-contrast CT, followed by Adrenal protocol CT with washout, then FDG-PET scan, and finally Image-guided percutaneous biopsy.
The algorithm for evaluating an adrenal incidentaloma follows a strict sequence from least invasive and most specific for common benign lesions, to most invasive for indeterminate masses. A non-contrast CT easily identifies benign lipid-rich adenomas (the most common finding). If the mass is lipid-poor ( HU), a contrast-enhanced washout CT distinguishes rapidly washing-out adenomas from malignancies. If still indeterminate, functional imaging like an FDG-PET scan assesses metabolic activity. Finally, an image-guided biopsy is reserved solely for masses remaining indeterminate when tissue diagnosis will change the management plan.
Adım Adım Çözüm
Anahtar Kavram
The stepwise radiologic evaluation of an adrenal incidentaloma prioritizes non-invasive characterization based on lipid content and vascular washout before considering functional imaging or invasive biopsy.
Alternatif Yöntem
Chemical shift magnetic resonance imaging (MRI) can be utilized as a direct alternative to the adrenal protocol CT with contrast washout for the second step of characterization. Chemical shift MRI detects microscopic intracellular lipid by demonstrating a diagnostic loss of signal intensity on out-of-phase images compared to in-phase images.
Tahmini Süre:1m 30s